CLINICAL_TRIALS
trial_result
· 2012-04-05
Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 clinical trial evaluating adalimumab in Japanese patients with rheumatoid arthritis has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-04-05